← Leaderboards
Martin Ernesto Fernandez-Zapico
Mayo Clinic Rochester
$10,185,222
Attributed
$16,353,889
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,353,889 · 9
By mechanism
R01$14,374,070 · 6
P50$1,833,965 · 2
R03$145,854 · 1
Top collaborators
- Lewis R Roberts12 shared
- Aminah Jatoi6 shared
- Hu Li5 shared
- Min Li5 shared
- Gloria M. Petersen5 shared
- Michael T Barrett2 shared
- Mitesh Borad2 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Richard G Vile$15,977,609
- Tamas Ordog$12,620,237
- Simon J Gibbons$1,049,400
- Saravut Weroha$5,625,190
- Cheryl A Conover$8,047,873
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularBasePathway InteractionsMalignant NeoplasmsMalignant Neoplasm Of PancreasMediatingTumorNovel Therapeutic InterventionTranscription FactorEffective TherapyFutureIn VivoInsightGli GeneLeadCause Of DeathReceptorDiagnosisCessation Of LifeTherapeutic TargetFoundationsOverexpressionIn VitroOperative Surgical Procedures
Grant awards (55)
New Therapuetics for Pancreatic Cancer$598,329
R01 · FY2025 · CA · contact PI
New Therapuetics for Pancreatic Cancer$568,413
R01 · FY2024 · CA · contact PI
New Therapuetics for Pancreatic Cancer$586,363
R01 · FY2023 · CA · contact PI
New Therapuetics for Pancreatic Cancer$600,834
R01 · FY2022 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$590,577
R01 · FY2020 · CA
Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544
R01 · FY2020 · CA
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$583,253
R01 · FY2019 · CA
Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$452,547
R01 · FY2019 · CA
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer$332,649
R01 · FY2019 · CA
Mechanism of Pancreatic Carcinogenesis$329,991
R01 · FY2019 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$601,292
R01 · FY2018 · CA
Mechanism of Pancreatic Carcinogenesis$343,220
R01 · FY2018 · CA · contact PI
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer$342,938
R01 · FY2018 · CA
Developmental Research Program$51,386
P50 · FY2018 · CA · contact PI
Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$1
R01 · FY2018 · CA
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$590,577
R01 · FY2017 · CA
Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544
R01 · FY2017 · CA
Mechanism of Pancreatic Carcinogenesis$344,108
R01 · FY2017 · CA · contact PI
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer$342,938
R01 · FY2017 · CA
Developmental Research Program$118,454
P50 · FY2017 · CA · contact PI
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds$578,620
R01 · FY2016 · CA
Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544
R01 · FY2016 · CA
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer$347,191
R01 · FY2016 · CA
Mechanism of Pancreatic Carcinogenesis$344,108
R01 · FY2016 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$327,228
R01 · FY2016 · CA
Developmental Research Program$48,504
P50 · FY2016 · CA · contact PI
Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle$466,544
R01 · FY2015 · CA
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer$362,685
R01 · FY2015 · CA
Mechanism of Pancreatic Carcinogenesis$344,108
R01 · FY2015 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$327,228
R01 · FY2015 · CA
Developmental Research Program$49,118
P50 · FY2015 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$13,348
R01 · FY2015 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$317,411
R01 · FY2014 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$93,306
R01 · FY2014 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$93,306
R01 · FY2014 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$51,791
R01 · FY2014 · CA
Developmental Research Program$51,468
P50 · FY2014 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$307,594
R01 · FY2013 · CA
Hedgehog and EGF interaction: a novel therapeutic approach for pancreatic cancer$257,291
R01 · FY2013 · CA · contact PI
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer$212,888
P50 · FY2013 · CA · contact PI
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$67,308
R01 · FY2013 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$44,719
R01 · FY2013 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$40,044
R01 · FY2013 · CA
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma$327,228
R01 · FY2012 · CA
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer$278,115
P50 · FY2012 · CA · contact PI
Hedgehog and EGF interaction: a novel therapeutic approach for pancreatic cancer$273,714
R01 · FY2012 · CA · contact PI
Hedgehog and EGF interaction: a novel therapeutic approach for pancreatic cancer$273,714
R01 · FY2011 · CA · contact PI
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer$265,210
P50 · FY2011 · CA · contact PI
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer$278,912
P50 · FY2010 · CA · contact PI
Hedgehog and EGF interaction: a novel therapeutic approach for pancreatic cancer$253,961
R01 · FY2010 · CA · contact PI
Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer$280,225
P50 · FY2009 · CA · contact PI
Hedgehog and EGF interaction: a novel therapeutic approach for pancreatic cancer$253,961
R01 · FY2009 · CA · contact PI
P-3: Hedgehog and EGF Pathway Interaction: A Novel Approach for a Multi-Target$199,685
P50 · FY2008 · CA · contact PI
Hedgehog-mediated survival mechanisms in pancreatic cancer$71,854
R03 · FY2007 · CA · contact PI
Hedgehog-mediated survival mechanisms in pancreatic cancer$74,000
R03 · FY2006 · CA · contact PI